Guardant Health, Inc.
GH- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001576280
In the last 90 days, Guardant Health, Inc. insiders filed 0 open-market purchases and 12 sales; 600 institutions reported holding it in 13F filings for Q2 2026, worth $20.0B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Guardant Health, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 366
- +26 vs. Q1 2025
- Shares held
- 124.3M
- +4.60M (+3.8%) vs. Q1 2025
- Total value
- $6.47B
- +$1.37B (+26.8%) vs. Q1 2025
- New holders
- 70
- 128 more added
- Sold out
- 44
- 115 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 600 | $20.0B |
| Q1 2026 | 486 | $12.5B |
| Q4 2025 | 498 | $13.4B |
| Q3 2025 | 396 | $7.65B |
| Q2 2025 | 366 | $6.47B |
| Q1 2025 | 342 | $5.10B |
| Q4 2024 | 298 | $3.65B |
| Q3 2024 | 271 | $2.86B |
| Q2 2024 | 282 | $3.32B |
| Q1 2024 | 258 | $2.30B |
| Q4 2023 | 295 | $2.99B |
| Q3 2023 | 297 | $3.21B |
| Q2 2023 | 301 | $3.95B |
| Q1 2023 | 280 | $2.17B |
| Q4 2022 | 292 | $2.53B |
| Q3 2022 | 328 | $5.04B |
| Q2 2022 | 333 | $3.75B |
| Q1 2022 | 356 | $6.11B |
| Q4 2021 | 397 | $9.24B |
| Q3 2021 | 375 | $11.8B |
| Q2 2021 | 417 | $11.1B |
| Q1 2021 | 420 | $13.9B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Guardant Health, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quent Capital, LLC | 0 | $0 | 0.00% | −132−100.0% | Sold out |
| Dynamic Wealth Strategies, LLC | 0 | $0 | 0.00% | −119−100.0% | Sold out |
| Anderson Financial Strategies, LLC | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Estabrook Capital Management | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Global Financial Private Client, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| CAPROCK Group, Inc. | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |